CLF, CLNO, RAD, PWRM, ENMD, NSM – Stock Reports And Updates! from...
Cliffs Natural Resources Inc. (NYSE:CLF) and Consolidated Thompson Iron Mines Limited (TSX:CLM.TO) jointly announced that Cliffs has closed on its acquisition of Consolidated Thompson. Cliffs...
View ArticleETR, SM, PWRM, CLNO, AGP – NYSE Weekend Stock Reports And Updates! From...
Entergy Corporation (NYSE:ETR) announced it is donating a minimum of $80,000 to disaster relief agencies helping people affected by recent tornadoes and flooding that have devastated communities...
View ArticleFREE, CLNO, LVLT, PWRM, OIIM – NASDAQ Stock Reports And News! From...
FreeSeas Inc. (Nasdaq:FREE) a transporter of dry-bulk cargoes through the ownership and operation of a fleet of Handysize and Handymax vessels, announced that it is extending the expiration date and...
View ArticleJCI, PWRM, QTM, NHPR, PCG- NYSE Stock Market Reports! From StockHotTips.com
Johnson Controls, Inc. (NYSE:JCI) and MAC S.A. have launched their joint venture in Colombia to produce and sell lead-acid batteries in the Central and South American regions. The companies announced...
View ArticleProtoKinetix Outlines AAGP™ Values in CEO Interview
VANCOUVER, British Columbia–(CRWENEWSWIRE)– ProtoKinetix (OTCBB:PKTX.OB) (www.protokinetix.com), a biotechnology company that has developed and patented a family of synthetic anti-aging glycopeptides...
View ArticleSpherix Announces Results from New Preclinical Studies Showing SPX-106T...
Results to Be Presented Wednesday, October 26, at AAPS National Meeting in Washington, DC BETHESDA, MD, Oct. 24, 2011 (CRWENEWSWIRE) — Spherix Incorporated (NASDAQ:SPEX) — an innovator in...
View ArticleSpherix Announces Successful Completion of Important Toxicology Study of SPX-106
Readies IND Filing BETHESDA, MD, Jan 11, 2012 (CRWENEWSWIRE) — Spherix Incorporated (NASDAQ:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and...
View ArticlePAREXEL Reports Second Quarter Fiscal Year 2012 Financial Results
- Consolidated service revenue of $333.2 million grew 9.5% year-over-year - GAAP operating margin of 6.8%; adjusted operating margin of 7.1% excluding net restructuring charges of $1.2 million - GAAP...
View ArticleDiscovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for...
SURFAXIN is the First FDA-Approved Synthetic, Peptide-Containing Surfactant Conference Call Tomorrow at 10 a.m. EST WARRINGTON, Pa., March 6, 2012 (CRWENewswire) — Discovery Laboratories, Inc. (NASDAQ:...
View ArticleSPX-106T Arrests Development of Atherosclerotic Plaques in Mouse Model of...
BETHESDA, Md., March 7, 2012 (CRWENewswire) — Spherix Incorporated (NASDAQ: SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of...
View Article
